CVS vs LEN · P/E 16, rev $402.07B vs rev $34.19B
CVS Health Corp (CVS) versus LEN (LEN) — a side-by-side from cached financials, not a winner call.
CVS Health Corp (CVS) is a healthcare plans company listed on US.
LEN (LEN) common stock.
Latest reported CVS revenue for 2025-12-31 was $402.07B. Net income was $1.77B. Revenue was up 7.8% from 2024-12-31 to 2025-12-31. CVS currently screens at market cap $86.20B and trailing P/E 16.3.
Latest reported LEN revenue for 2025-11-30 was $34.19B. Net income was $2.08B. Revenue was down 3.5% from 2024-11-30 to 2025-11-30. LEN currently screens at market cap $0.
CVS currently screens at market cap $86.20B and trailing P/E 16.3. LEN currently screens at market cap $0.
Not investment advice. Open the CVS and LEN stock pages for the full models.
Not investment advice.